nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—CYP2D6—breast cancer	0.18	0.583	CbGaD
Doxazosin—ABCB1—breast cancer	0.129	0.417	CbGaD
Doxazosin—ABCB1—Toremifene—breast cancer	0.0393	0.129	CbGbCtD
Doxazosin—CYP2C19—Lapatinib—breast cancer	0.0355	0.117	CbGbCtD
Doxazosin—CYP2D6—Idarubicin—breast cancer	0.0307	0.101	CbGbCtD
Doxazosin—ABCB1—Lapatinib—breast cancer	0.0287	0.0943	CbGbCtD
Doxazosin—CYP2C19—Tamoxifen—breast cancer	0.0178	0.0585	CbGbCtD
Doxazosin—ABCB1—Vinorelbine—breast cancer	0.0159	0.0523	CbGbCtD
Doxazosin—CYP2D6—Vinorelbine—breast cancer	0.015	0.0493	CbGbCtD
Doxazosin—ABCB1—Tamoxifen—breast cancer	0.0144	0.0472	CbGbCtD
Doxazosin—ABCB1—Mitoxantrone—breast cancer	0.014	0.0461	CbGbCtD
Doxazosin—CYP2D6—Tamoxifen—breast cancer	0.0135	0.0445	CbGbCtD
Doxazosin—ABCB1—Gemcitabine—breast cancer	0.0124	0.0407	CbGbCtD
Doxazosin—ABCB1—Paclitaxel—breast cancer	0.0112	0.0368	CbGbCtD
Doxazosin—ABCB1—Irinotecan—breast cancer	0.011	0.0363	CbGbCtD
Doxazosin—ABCB1—Vinblastine—breast cancer	0.0098	0.0322	CbGbCtD
Doxazosin—CYP2D6—Vinblastine—breast cancer	0.00923	0.0304	CbGbCtD
Doxazosin—ABCB1—Docetaxel—breast cancer	0.00808	0.0266	CbGbCtD
Doxazosin—ABCB1—Doxorubicin—breast cancer	0.00602	0.0198	CbGbCtD
Doxazosin—ABCB1—Methotrexate—breast cancer	0.00583	0.0192	CbGbCtD
Doxazosin—CYP2D6—Doxorubicin—breast cancer	0.00567	0.0187	CbGbCtD
Doxazosin—Prazosin—MT3—breast cancer	0.00244	0.391	CrCbGaD
Doxazosin—Donepezil—ACHE—breast cancer	0.00127	0.204	CrCbGaD
Doxazosin—KCNH6—uterus—breast cancer	0.00104	0.0707	CbGeAlD
Doxazosin—KCNH6—female reproductive system—breast cancer	0.000936	0.0636	CbGeAlD
Doxazosin—ADRA1D—epithelium—breast cancer	0.000698	0.0474	CbGeAlD
Doxazosin—KCNH2—nipple—breast cancer	0.000575	0.0391	CbGeAlD
Doxazosin—ADRA1D—female reproductive system—breast cancer	0.000518	0.0352	CbGeAlD
Doxazosin—ORM1—endometrium—breast cancer	0.000515	0.035	CbGeAlD
Doxazosin—Prazosin—ABCG2—breast cancer	0.000483	0.0776	CrCbGaD
Doxazosin—ADRA2A—nipple—breast cancer	0.000453	0.0308	CbGeAlD
Doxazosin—ADRA1D—endocrine gland—breast cancer	0.000439	0.0298	CbGeAlD
Doxazosin—ORM1—female reproductive system—breast cancer	0.000427	0.029	CbGeAlD
Doxazosin—Donepezil—CYP2D6—breast cancer	0.000411	0.066	CrCbGaD
Doxazosin—Alfuzosin—CYP3A4—breast cancer	0.000403	0.0647	CrCbGaD
Doxazosin—ORM1—bone marrow—breast cancer	0.000403	0.0274	CbGeAlD
Doxazosin—ADRA1A—epithelium—breast cancer	0.000401	0.0272	CbGeAlD
Doxazosin—Prazosin—CYP1A1—breast cancer	0.000379	0.0608	CrCbGaD
Doxazosin—ORM1—endocrine gland—breast cancer	0.000361	0.0245	CbGeAlD
Doxazosin—Donepezil—CYP3A4—breast cancer	0.000353	0.0566	CrCbGaD
Doxazosin—KCNH2—endometrium—breast cancer	0.000347	0.0236	CbGeAlD
Doxazosin—ADRA1A—adipose tissue—breast cancer	0.000324	0.022	CbGeAlD
Doxazosin—KCNH2—uterus—breast cancer	0.00032	0.0217	CbGeAlD
Doxazosin—KCNH2—pituitary gland—breast cancer	0.000314	0.0213	CbGeAlD
Doxazosin—Terazosin—ABCB1—breast cancer	0.000294	0.0471	CrCbGaD
Doxazosin—ADRA1A—adrenal gland—breast cancer	0.000291	0.0197	CbGeAlD
Doxazosin—KCNH2—female reproductive system—breast cancer	0.000288	0.0195	CbGeAlD
Doxazosin—KCNH2—adrenal gland—breast cancer	0.000281	0.0191	CbGeAlD
Doxazosin—ADRA2A—endometrium—breast cancer	0.000273	0.0186	CbGeAlD
Doxazosin—KCNH2—bone marrow—breast cancer	0.000272	0.0184	CbGeAlD
Doxazosin—KCNH2—female gonad—breast cancer	0.000262	0.0178	CbGeAlD
Doxazosin—CYP2C19—endocrine gland—breast cancer	0.000255	0.0173	CbGeAlD
Doxazosin—ADRA1A—endocrine gland—breast cancer	0.000252	0.0171	CbGeAlD
Doxazosin—ADRA2A—uterus—breast cancer	0.000252	0.0171	CbGeAlD
Doxazosin—ORM1—lymph node—breast cancer	0.00025	0.017	CbGeAlD
Doxazosin—ADRA2A—pituitary gland—breast cancer	0.000247	0.0168	CbGeAlD
Doxazosin—ADRA2A—adipose tissue—breast cancer	0.000246	0.0167	CbGeAlD
Doxazosin—KCNH2—endocrine gland—breast cancer	0.000243	0.0165	CbGeAlD
Doxazosin—ADRA2A—female reproductive system—breast cancer	0.000226	0.0154	CbGeAlD
Doxazosin—ADRA2A—adrenal gland—breast cancer	0.000221	0.015	CbGeAlD
Doxazosin—ABCB1—embryo—breast cancer	0.000208	0.0141	CbGeAlD
Doxazosin—ADRA2A—female gonad—breast cancer	0.000206	0.014	CbGeAlD
Doxazosin—Prazosin—ABCB1—breast cancer	0.000201	0.0323	CrCbGaD
Doxazosin—ADRA2A—endocrine gland—breast cancer	0.000192	0.013	CbGeAlD
Doxazosin—CYP2D6—female reproductive system—breast cancer	0.000175	0.0119	CbGeAlD
Doxazosin—ABCB1—epithelium—breast cancer	0.00017	0.0115	CbGeAlD
Doxazosin—KCNH2—lymph node—breast cancer	0.000168	0.0114	CbGeAlD
Doxazosin—CYP2D6—female gonad—breast cancer	0.00016	0.0108	CbGeAlD
Doxazosin—ABCB1—endometrium—breast cancer	0.000152	0.0103	CbGeAlD
Doxazosin—CYP2D6—endocrine gland—breast cancer	0.000148	0.0101	CbGeAlD
Doxazosin—ABCB1—uterus—breast cancer	0.00014	0.00953	CbGeAlD
Doxazosin—ABCB1—pituitary gland—breast cancer	0.000138	0.00936	CbGeAlD
Doxazosin—ABCB1—adipose tissue—breast cancer	0.000137	0.00932	CbGeAlD
Doxazosin—ADRA2A—lymph node—breast cancer	0.000132	0.009	CbGeAlD
Doxazosin—ABCB1—female reproductive system—breast cancer	0.000126	0.00857	CbGeAlD
Doxazosin—ABCB1—adrenal gland—breast cancer	0.000123	0.00836	CbGeAlD
Doxazosin—ABCB1—bone marrow—breast cancer	0.000119	0.00809	CbGeAlD
Doxazosin—ABCB1—female gonad—breast cancer	0.000115	0.0078	CbGeAlD
Doxazosin—ABCB1—endocrine gland—breast cancer	0.000107	0.00725	CbGeAlD
Doxazosin—ABCB1—lymph node—breast cancer	7.38e-05	0.00501	CbGeAlD
Doxazosin—Somnolence—Docetaxel—breast cancer	4.33e-05	0.000157	CcSEcCtD
Doxazosin—Mental disorder—Methotrexate—breast cancer	4.32e-05	0.000157	CcSEcCtD
Doxazosin—Rash—Gemcitabine—breast cancer	4.32e-05	0.000157	CcSEcCtD
Doxazosin—Dermatitis—Gemcitabine—breast cancer	4.32e-05	0.000156	CcSEcCtD
Doxazosin—Eye disorder—Epirubicin—breast cancer	4.32e-05	0.000156	CcSEcCtD
Doxazosin—Tinnitus—Epirubicin—breast cancer	4.31e-05	0.000156	CcSEcCtD
Doxazosin—Malnutrition—Methotrexate—breast cancer	4.3e-05	0.000156	CcSEcCtD
Doxazosin—Headache—Gemcitabine—breast cancer	4.3e-05	0.000156	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Capecitabine—breast cancer	4.29e-05	0.000156	CcSEcCtD
Doxazosin—Flushing—Epirubicin—breast cancer	4.29e-05	0.000155	CcSEcCtD
Doxazosin—Vomiting—Fluorouracil—breast cancer	4.29e-05	0.000155	CcSEcCtD
Doxazosin—Rhinitis—Doxorubicin—breast cancer	4.28e-05	0.000155	CcSEcCtD
Doxazosin—Dyspepsia—Docetaxel—breast cancer	4.28e-05	0.000155	CcSEcCtD
Doxazosin—Hepatitis—Doxorubicin—breast cancer	4.27e-05	0.000155	CcSEcCtD
Doxazosin—Insomnia—Capecitabine—breast cancer	4.26e-05	0.000154	CcSEcCtD
Doxazosin—Hypoaesthesia—Doxorubicin—breast cancer	4.25e-05	0.000154	CcSEcCtD
Doxazosin—Rash—Fluorouracil—breast cancer	4.25e-05	0.000154	CcSEcCtD
Doxazosin—Dermatitis—Fluorouracil—breast cancer	4.25e-05	0.000154	CcSEcCtD
Doxazosin—Pharyngitis—Doxorubicin—breast cancer	4.24e-05	0.000154	CcSEcCtD
Doxazosin—Paraesthesia—Capecitabine—breast cancer	4.23e-05	0.000153	CcSEcCtD
Doxazosin—Decreased appetite—Docetaxel—breast cancer	4.23e-05	0.000153	CcSEcCtD
Doxazosin—Hypersensitivity—Paclitaxel—breast cancer	4.23e-05	0.000153	CcSEcCtD
Doxazosin—Headache—Fluorouracil—breast cancer	4.22e-05	0.000153	CcSEcCtD
Doxazosin—Dysgeusia—Methotrexate—breast cancer	4.21e-05	0.000152	CcSEcCtD
Doxazosin—Dyspnoea—Capecitabine—breast cancer	4.2e-05	0.000152	CcSEcCtD
Doxazosin—Fatigue—Docetaxel—breast cancer	4.19e-05	0.000152	CcSEcCtD
Doxazosin—Nausea—Mitoxantrone—breast cancer	4.18e-05	0.000151	CcSEcCtD
Doxazosin—Nausea—Irinotecan—breast cancer	4.18e-05	0.000151	CcSEcCtD
Doxazosin—Pain—Docetaxel—breast cancer	4.16e-05	0.000151	CcSEcCtD
Doxazosin—Constipation—Docetaxel—breast cancer	4.16e-05	0.000151	CcSEcCtD
Doxazosin—Back pain—Methotrexate—breast cancer	4.16e-05	0.000151	CcSEcCtD
Doxazosin—Dyspepsia—Capecitabine—breast cancer	4.15e-05	0.00015	CcSEcCtD
Doxazosin—Chills—Epirubicin—breast cancer	4.14e-05	0.00015	CcSEcCtD
Doxazosin—Arrhythmia—Epirubicin—breast cancer	4.13e-05	0.00015	CcSEcCtD
Doxazosin—Visual impairment—Doxorubicin—breast cancer	4.12e-05	0.000149	CcSEcCtD
Doxazosin—Asthenia—Paclitaxel—breast cancer	4.12e-05	0.000149	CcSEcCtD
Doxazosin—Decreased appetite—Capecitabine—breast cancer	4.09e-05	0.000148	CcSEcCtD
Doxazosin—Alopecia—Epirubicin—breast cancer	4.08e-05	0.000148	CcSEcCtD
Doxazosin—Nausea—Gemcitabine—breast cancer	4.07e-05	0.000148	CcSEcCtD
Doxazosin—Fatigue—Capecitabine—breast cancer	4.06e-05	0.000147	CcSEcCtD
Doxazosin—Pruritus—Paclitaxel—breast cancer	4.06e-05	0.000147	CcSEcCtD
Doxazosin—Vision blurred—Methotrexate—breast cancer	4.05e-05	0.000147	CcSEcCtD
Doxazosin—Mental disorder—Epirubicin—breast cancer	4.05e-05	0.000147	CcSEcCtD
Doxazosin—Constipation—Capecitabine—breast cancer	4.03e-05	0.000146	CcSEcCtD
Doxazosin—Pain—Capecitabine—breast cancer	4.03e-05	0.000146	CcSEcCtD
Doxazosin—Malnutrition—Epirubicin—breast cancer	4.02e-05	0.000146	CcSEcCtD
Doxazosin—Feeling abnormal—Docetaxel—breast cancer	4.01e-05	0.000145	CcSEcCtD
Doxazosin—Nausea—Fluorouracil—breast cancer	4e-05	0.000145	CcSEcCtD
Doxazosin—Eye disorder—Doxorubicin—breast cancer	3.99e-05	0.000145	CcSEcCtD
Doxazosin—Ill-defined disorder—Methotrexate—breast cancer	3.99e-05	0.000144	CcSEcCtD
Doxazosin—Tinnitus—Doxorubicin—breast cancer	3.98e-05	0.000144	CcSEcCtD
Doxazosin—Gastrointestinal pain—Docetaxel—breast cancer	3.98e-05	0.000144	CcSEcCtD
Doxazosin—Flushing—Doxorubicin—breast cancer	3.97e-05	0.000144	CcSEcCtD
Doxazosin—Flatulence—Epirubicin—breast cancer	3.96e-05	0.000144	CcSEcCtD
Doxazosin—Tension—Epirubicin—breast cancer	3.95e-05	0.000143	CcSEcCtD
Doxazosin—Dysgeusia—Epirubicin—breast cancer	3.94e-05	0.000143	CcSEcCtD
Doxazosin—Diarrhoea—Paclitaxel—breast cancer	3.93e-05	0.000142	CcSEcCtD
Doxazosin—Nervousness—Epirubicin—breast cancer	3.91e-05	0.000142	CcSEcCtD
Doxazosin—Back pain—Epirubicin—breast cancer	3.89e-05	0.000141	CcSEcCtD
Doxazosin—Feeling abnormal—Capecitabine—breast cancer	3.88e-05	0.000141	CcSEcCtD
Doxazosin—Malaise—Methotrexate—breast cancer	3.87e-05	0.00014	CcSEcCtD
Doxazosin—Muscle spasms—Epirubicin—breast cancer	3.87e-05	0.00014	CcSEcCtD
Doxazosin—Vertigo—Methotrexate—breast cancer	3.86e-05	0.00014	CcSEcCtD
Doxazosin—Gastrointestinal pain—Capecitabine—breast cancer	3.85e-05	0.00014	CcSEcCtD
Doxazosin—Body temperature increased—Docetaxel—breast cancer	3.85e-05	0.000139	CcSEcCtD
Doxazosin—Abdominal pain—Docetaxel—breast cancer	3.85e-05	0.000139	CcSEcCtD
Doxazosin—Leukopenia—Methotrexate—breast cancer	3.85e-05	0.000139	CcSEcCtD
Doxazosin—Chills—Doxorubicin—breast cancer	3.83e-05	0.000139	CcSEcCtD
Doxazosin—Arrhythmia—Doxorubicin—breast cancer	3.82e-05	0.000138	CcSEcCtD
Doxazosin—Dizziness—Paclitaxel—breast cancer	3.8e-05	0.000138	CcSEcCtD
Doxazosin—Vision blurred—Epirubicin—breast cancer	3.79e-05	0.000137	CcSEcCtD
Doxazosin—Alopecia—Doxorubicin—breast cancer	3.78e-05	0.000137	CcSEcCtD
Doxazosin—Cough—Methotrexate—breast cancer	3.75e-05	0.000136	CcSEcCtD
Doxazosin—Mental disorder—Doxorubicin—breast cancer	3.74e-05	0.000136	CcSEcCtD
Doxazosin—Urticaria—Capecitabine—breast cancer	3.74e-05	0.000136	CcSEcCtD
Doxazosin—Ill-defined disorder—Epirubicin—breast cancer	3.73e-05	0.000135	CcSEcCtD
Doxazosin—Abdominal pain—Capecitabine—breast cancer	3.72e-05	0.000135	CcSEcCtD
Doxazosin—Body temperature increased—Capecitabine—breast cancer	3.72e-05	0.000135	CcSEcCtD
Doxazosin—Convulsion—Methotrexate—breast cancer	3.72e-05	0.000135	CcSEcCtD
Doxazosin—Malnutrition—Doxorubicin—breast cancer	3.72e-05	0.000135	CcSEcCtD
Doxazosin—Agitation—Epirubicin—breast cancer	3.7e-05	0.000134	CcSEcCtD
Doxazosin—Flatulence—Doxorubicin—breast cancer	3.67e-05	0.000133	CcSEcCtD
Doxazosin—Arthralgia—Methotrexate—breast cancer	3.66e-05	0.000133	CcSEcCtD
Doxazosin—Chest pain—Methotrexate—breast cancer	3.66e-05	0.000133	CcSEcCtD
Doxazosin—Myalgia—Methotrexate—breast cancer	3.66e-05	0.000133	CcSEcCtD
Doxazosin—Tension—Doxorubicin—breast cancer	3.65e-05	0.000132	CcSEcCtD
Doxazosin—Vomiting—Paclitaxel—breast cancer	3.65e-05	0.000132	CcSEcCtD
Doxazosin—Dysgeusia—Doxorubicin—breast cancer	3.64e-05	0.000132	CcSEcCtD
Doxazosin—Malaise—Epirubicin—breast cancer	3.63e-05	0.000131	CcSEcCtD
Doxazosin—Rash—Paclitaxel—breast cancer	3.62e-05	0.000131	CcSEcCtD
Doxazosin—Dermatitis—Paclitaxel—breast cancer	3.62e-05	0.000131	CcSEcCtD
Doxazosin—Discomfort—Methotrexate—breast cancer	3.61e-05	0.000131	CcSEcCtD
Doxazosin—Nervousness—Doxorubicin—breast cancer	3.61e-05	0.000131	CcSEcCtD
Doxazosin—Vertigo—Epirubicin—breast cancer	3.61e-05	0.000131	CcSEcCtD
Doxazosin—Syncope—Epirubicin—breast cancer	3.61e-05	0.000131	CcSEcCtD
Doxazosin—Leukopenia—Epirubicin—breast cancer	3.6e-05	0.00013	CcSEcCtD
Doxazosin—Back pain—Doxorubicin—breast cancer	3.6e-05	0.00013	CcSEcCtD
Doxazosin—Headache—Paclitaxel—breast cancer	3.6e-05	0.00013	CcSEcCtD
Doxazosin—Hypersensitivity—Docetaxel—breast cancer	3.58e-05	0.00013	CcSEcCtD
Doxazosin—Muscle spasms—Doxorubicin—breast cancer	3.58e-05	0.00013	CcSEcCtD
Doxazosin—Palpitations—Epirubicin—breast cancer	3.55e-05	0.000129	CcSEcCtD
Doxazosin—Confusional state—Methotrexate—breast cancer	3.54e-05	0.000128	CcSEcCtD
Doxazosin—Loss of consciousness—Epirubicin—breast cancer	3.53e-05	0.000128	CcSEcCtD
Doxazosin—Cough—Epirubicin—breast cancer	3.51e-05	0.000127	CcSEcCtD
Doxazosin—Vision blurred—Doxorubicin—breast cancer	3.51e-05	0.000127	CcSEcCtD
Doxazosin—Asthenia—Docetaxel—breast cancer	3.49e-05	0.000126	CcSEcCtD
Doxazosin—Convulsion—Epirubicin—breast cancer	3.48e-05	0.000126	CcSEcCtD
Doxazosin—Infection—Methotrexate—breast cancer	3.48e-05	0.000126	CcSEcCtD
Doxazosin—Hypertension—Epirubicin—breast cancer	3.47e-05	0.000126	CcSEcCtD
Doxazosin—Hypersensitivity—Capecitabine—breast cancer	3.47e-05	0.000126	CcSEcCtD
Doxazosin—Ill-defined disorder—Doxorubicin—breast cancer	3.45e-05	0.000125	CcSEcCtD
Doxazosin—Pruritus—Docetaxel—breast cancer	3.44e-05	0.000125	CcSEcCtD
Doxazosin—Thrombocytopenia—Methotrexate—breast cancer	3.43e-05	0.000124	CcSEcCtD
Doxazosin—Arthralgia—Epirubicin—breast cancer	3.42e-05	0.000124	CcSEcCtD
Doxazosin—Chest pain—Epirubicin—breast cancer	3.42e-05	0.000124	CcSEcCtD
Doxazosin—Myalgia—Epirubicin—breast cancer	3.42e-05	0.000124	CcSEcCtD
Doxazosin—Agitation—Doxorubicin—breast cancer	3.42e-05	0.000124	CcSEcCtD
Doxazosin—Anxiety—Epirubicin—breast cancer	3.41e-05	0.000124	CcSEcCtD
Doxazosin—Nausea—Paclitaxel—breast cancer	3.41e-05	0.000124	CcSEcCtD
Doxazosin—Skin disorder—Methotrexate—breast cancer	3.41e-05	0.000123	CcSEcCtD
Doxazosin—Hyperhidrosis—Methotrexate—breast cancer	3.39e-05	0.000123	CcSEcCtD
Doxazosin—Discomfort—Epirubicin—breast cancer	3.38e-05	0.000123	CcSEcCtD
Doxazosin—Asthenia—Capecitabine—breast cancer	3.38e-05	0.000122	CcSEcCtD
Doxazosin—Malaise—Doxorubicin—breast cancer	3.36e-05	0.000122	CcSEcCtD
Doxazosin—Dry mouth—Epirubicin—breast cancer	3.35e-05	0.000121	CcSEcCtD
Doxazosin—Vertigo—Doxorubicin—breast cancer	3.34e-05	0.000121	CcSEcCtD
Doxazosin—Anorexia—Methotrexate—breast cancer	3.34e-05	0.000121	CcSEcCtD
Doxazosin—Syncope—Doxorubicin—breast cancer	3.34e-05	0.000121	CcSEcCtD
Doxazosin—Pruritus—Capecitabine—breast cancer	3.33e-05	0.000121	CcSEcCtD
Doxazosin—Leukopenia—Doxorubicin—breast cancer	3.33e-05	0.000121	CcSEcCtD
Doxazosin—Diarrhoea—Docetaxel—breast cancer	3.33e-05	0.000121	CcSEcCtD
Doxazosin—Confusional state—Epirubicin—breast cancer	3.31e-05	0.00012	CcSEcCtD
Doxazosin—Palpitations—Doxorubicin—breast cancer	3.29e-05	0.000119	CcSEcCtD
Doxazosin—Oedema—Epirubicin—breast cancer	3.28e-05	0.000119	CcSEcCtD
Doxazosin—Hypotension—Methotrexate—breast cancer	3.28e-05	0.000119	CcSEcCtD
Doxazosin—Loss of consciousness—Doxorubicin—breast cancer	3.27e-05	0.000118	CcSEcCtD
Doxazosin—Infection—Epirubicin—breast cancer	3.26e-05	0.000118	CcSEcCtD
Doxazosin—Cough—Doxorubicin—breast cancer	3.25e-05	0.000118	CcSEcCtD
Doxazosin—Shock—Epirubicin—breast cancer	3.23e-05	0.000117	CcSEcCtD
Doxazosin—Convulsion—Doxorubicin—breast cancer	3.22e-05	0.000117	CcSEcCtD
Doxazosin—Diarrhoea—Capecitabine—breast cancer	3.22e-05	0.000117	CcSEcCtD
Doxazosin—Dizziness—Docetaxel—breast cancer	3.22e-05	0.000117	CcSEcCtD
Doxazosin—Thrombocytopenia—Epirubicin—breast cancer	3.21e-05	0.000116	CcSEcCtD
Doxazosin—Hypertension—Doxorubicin—breast cancer	3.21e-05	0.000116	CcSEcCtD
Doxazosin—Tachycardia—Epirubicin—breast cancer	3.2e-05	0.000116	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Methotrexate—breast cancer	3.19e-05	0.000116	CcSEcCtD
Doxazosin—Skin disorder—Epirubicin—breast cancer	3.19e-05	0.000116	CcSEcCtD
Doxazosin—Hyperhidrosis—Epirubicin—breast cancer	3.17e-05	0.000115	CcSEcCtD
Doxazosin—Insomnia—Methotrexate—breast cancer	3.17e-05	0.000115	CcSEcCtD
Doxazosin—Myalgia—Doxorubicin—breast cancer	3.17e-05	0.000115	CcSEcCtD
Doxazosin—Arthralgia—Doxorubicin—breast cancer	3.17e-05	0.000115	CcSEcCtD
Doxazosin—Chest pain—Doxorubicin—breast cancer	3.17e-05	0.000115	CcSEcCtD
Doxazosin—Anxiety—Doxorubicin—breast cancer	3.16e-05	0.000114	CcSEcCtD
Doxazosin—Paraesthesia—Methotrexate—breast cancer	3.15e-05	0.000114	CcSEcCtD
Doxazosin—Discomfort—Doxorubicin—breast cancer	3.13e-05	0.000113	CcSEcCtD
Doxazosin—Anorexia—Epirubicin—breast cancer	3.13e-05	0.000113	CcSEcCtD
Doxazosin—Dyspnoea—Methotrexate—breast cancer	3.13e-05	0.000113	CcSEcCtD
Doxazosin—Somnolence—Methotrexate—breast cancer	3.12e-05	0.000113	CcSEcCtD
Doxazosin—Dizziness—Capecitabine—breast cancer	3.12e-05	0.000113	CcSEcCtD
Doxazosin—Dry mouth—Doxorubicin—breast cancer	3.1e-05	0.000112	CcSEcCtD
Doxazosin—Vomiting—Docetaxel—breast cancer	3.09e-05	0.000112	CcSEcCtD
Doxazosin—Dyspepsia—Methotrexate—breast cancer	3.09e-05	0.000112	CcSEcCtD
Doxazosin—Rash—Docetaxel—breast cancer	3.07e-05	0.000111	CcSEcCtD
Doxazosin—Hypotension—Epirubicin—breast cancer	3.07e-05	0.000111	CcSEcCtD
Doxazosin—Dermatitis—Docetaxel—breast cancer	3.06e-05	0.000111	CcSEcCtD
Doxazosin—Confusional state—Doxorubicin—breast cancer	3.06e-05	0.000111	CcSEcCtD
Doxazosin—Decreased appetite—Methotrexate—breast cancer	3.05e-05	0.00011	CcSEcCtD
Doxazosin—Headache—Docetaxel—breast cancer	3.05e-05	0.00011	CcSEcCtD
Doxazosin—Oedema—Doxorubicin—breast cancer	3.04e-05	0.00011	CcSEcCtD
Doxazosin—Fatigue—Methotrexate—breast cancer	3.02e-05	0.00011	CcSEcCtD
Doxazosin—Infection—Doxorubicin—breast cancer	3.02e-05	0.000109	CcSEcCtD
Doxazosin—Pain—Methotrexate—breast cancer	3e-05	0.000109	CcSEcCtD
Doxazosin—Vomiting—Capecitabine—breast cancer	3e-05	0.000109	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Epirubicin—breast cancer	2.99e-05	0.000108	CcSEcCtD
Doxazosin—Shock—Doxorubicin—breast cancer	2.99e-05	0.000108	CcSEcCtD
Doxazosin—Thrombocytopenia—Doxorubicin—breast cancer	2.97e-05	0.000108	CcSEcCtD
Doxazosin—Rash—Capecitabine—breast cancer	2.97e-05	0.000108	CcSEcCtD
Doxazosin—Insomnia—Epirubicin—breast cancer	2.97e-05	0.000108	CcSEcCtD
Doxazosin—Dermatitis—Capecitabine—breast cancer	2.97e-05	0.000108	CcSEcCtD
Doxazosin—Tachycardia—Doxorubicin—breast cancer	2.96e-05	0.000107	CcSEcCtD
Doxazosin—Headache—Capecitabine—breast cancer	2.95e-05	0.000107	CcSEcCtD
Doxazosin—Skin disorder—Doxorubicin—breast cancer	2.95e-05	0.000107	CcSEcCtD
Doxazosin—Paraesthesia—Epirubicin—breast cancer	2.95e-05	0.000107	CcSEcCtD
Doxazosin—Hyperhidrosis—Doxorubicin—breast cancer	2.94e-05	0.000106	CcSEcCtD
Doxazosin—Dyspnoea—Epirubicin—breast cancer	2.93e-05	0.000106	CcSEcCtD
Doxazosin—Somnolence—Epirubicin—breast cancer	2.92e-05	0.000106	CcSEcCtD
Doxazosin—Anorexia—Doxorubicin—breast cancer	2.89e-05	0.000105	CcSEcCtD
Doxazosin—Nausea—Docetaxel—breast cancer	2.89e-05	0.000105	CcSEcCtD
Doxazosin—Feeling abnormal—Methotrexate—breast cancer	2.89e-05	0.000105	CcSEcCtD
Doxazosin—Dyspepsia—Epirubicin—breast cancer	2.89e-05	0.000105	CcSEcCtD
Doxazosin—Gastrointestinal pain—Methotrexate—breast cancer	2.87e-05	0.000104	CcSEcCtD
Doxazosin—Decreased appetite—Epirubicin—breast cancer	2.85e-05	0.000103	CcSEcCtD
Doxazosin—Hypotension—Doxorubicin—breast cancer	2.84e-05	0.000103	CcSEcCtD
Doxazosin—Fatigue—Epirubicin—breast cancer	2.83e-05	0.000103	CcSEcCtD
Doxazosin—Pain—Epirubicin—breast cancer	2.81e-05	0.000102	CcSEcCtD
Doxazosin—Constipation—Epirubicin—breast cancer	2.81e-05	0.000102	CcSEcCtD
Doxazosin—Nausea—Capecitabine—breast cancer	2.8e-05	0.000101	CcSEcCtD
Doxazosin—Urticaria—Methotrexate—breast cancer	2.79e-05	0.000101	CcSEcCtD
Doxazosin—Abdominal pain—Methotrexate—breast cancer	2.77e-05	0.0001	CcSEcCtD
Doxazosin—Body temperature increased—Methotrexate—breast cancer	2.77e-05	0.0001	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.77e-05	0.0001	CcSEcCtD
Doxazosin—Insomnia—Doxorubicin—breast cancer	2.75e-05	9.95e-05	CcSEcCtD
Doxazosin—Paraesthesia—Doxorubicin—breast cancer	2.73e-05	9.88e-05	CcSEcCtD
Doxazosin—Dyspnoea—Doxorubicin—breast cancer	2.71e-05	9.81e-05	CcSEcCtD
Doxazosin—Feeling abnormal—Epirubicin—breast cancer	2.7e-05	9.8e-05	CcSEcCtD
Doxazosin—Somnolence—Doxorubicin—breast cancer	2.7e-05	9.78e-05	CcSEcCtD
Doxazosin—Gastrointestinal pain—Epirubicin—breast cancer	2.68e-05	9.72e-05	CcSEcCtD
Doxazosin—Dyspepsia—Doxorubicin—breast cancer	2.67e-05	9.69e-05	CcSEcCtD
Doxazosin—Decreased appetite—Doxorubicin—breast cancer	2.64e-05	9.56e-05	CcSEcCtD
Doxazosin—Fatigue—Doxorubicin—breast cancer	2.62e-05	9.49e-05	CcSEcCtD
Doxazosin—Urticaria—Epirubicin—breast cancer	2.61e-05	9.45e-05	CcSEcCtD
Doxazosin—Constipation—Doxorubicin—breast cancer	2.6e-05	9.41e-05	CcSEcCtD
Doxazosin—Pain—Doxorubicin—breast cancer	2.6e-05	9.41e-05	CcSEcCtD
Doxazosin—Body temperature increased—Epirubicin—breast cancer	2.59e-05	9.4e-05	CcSEcCtD
Doxazosin—Abdominal pain—Epirubicin—breast cancer	2.59e-05	9.4e-05	CcSEcCtD
Doxazosin—Hypersensitivity—Methotrexate—breast cancer	2.58e-05	9.36e-05	CcSEcCtD
Doxazosin—Asthenia—Methotrexate—breast cancer	2.52e-05	9.12e-05	CcSEcCtD
Doxazosin—Feeling abnormal—Doxorubicin—breast cancer	2.5e-05	9.07e-05	CcSEcCtD
Doxazosin—Gastrointestinal pain—Doxorubicin—breast cancer	2.48e-05	9e-05	CcSEcCtD
Doxazosin—Pruritus—Methotrexate—breast cancer	2.48e-05	8.99e-05	CcSEcCtD
Doxazosin—Hypersensitivity—Epirubicin—breast cancer	2.42e-05	8.76e-05	CcSEcCtD
Doxazosin—Urticaria—Doxorubicin—breast cancer	2.41e-05	8.74e-05	CcSEcCtD
Doxazosin—Body temperature increased—Doxorubicin—breast cancer	2.4e-05	8.7e-05	CcSEcCtD
Doxazosin—Abdominal pain—Doxorubicin—breast cancer	2.4e-05	8.7e-05	CcSEcCtD
Doxazosin—Diarrhoea—Methotrexate—breast cancer	2.4e-05	8.69e-05	CcSEcCtD
Doxazosin—Asthenia—Epirubicin—breast cancer	2.35e-05	8.53e-05	CcSEcCtD
Doxazosin—Pruritus—Epirubicin—breast cancer	2.32e-05	8.41e-05	CcSEcCtD
Doxazosin—Dizziness—Methotrexate—breast cancer	2.32e-05	8.4e-05	CcSEcCtD
Doxazosin—Diarrhoea—Epirubicin—breast cancer	2.25e-05	8.14e-05	CcSEcCtD
Doxazosin—Hypersensitivity—Doxorubicin—breast cancer	2.24e-05	8.11e-05	CcSEcCtD
Doxazosin—Vomiting—Methotrexate—breast cancer	2.23e-05	8.08e-05	CcSEcCtD
Doxazosin—Rash—Methotrexate—breast cancer	2.21e-05	8.01e-05	CcSEcCtD
Doxazosin—Dermatitis—Methotrexate—breast cancer	2.21e-05	8e-05	CcSEcCtD
Doxazosin—Headache—Methotrexate—breast cancer	2.2e-05	7.96e-05	CcSEcCtD
Doxazosin—Asthenia—Doxorubicin—breast cancer	2.18e-05	7.89e-05	CcSEcCtD
Doxazosin—Dizziness—Epirubicin—breast cancer	2.17e-05	7.86e-05	CcSEcCtD
Doxazosin—Pruritus—Doxorubicin—breast cancer	2.15e-05	7.78e-05	CcSEcCtD
Doxazosin—Vomiting—Epirubicin—breast cancer	2.09e-05	7.56e-05	CcSEcCtD
Doxazosin—Nausea—Methotrexate—breast cancer	2.08e-05	7.55e-05	CcSEcCtD
Doxazosin—Diarrhoea—Doxorubicin—breast cancer	2.08e-05	7.53e-05	CcSEcCtD
Doxazosin—Rash—Epirubicin—breast cancer	2.07e-05	7.5e-05	CcSEcCtD
Doxazosin—Dermatitis—Epirubicin—breast cancer	2.07e-05	7.49e-05	CcSEcCtD
Doxazosin—Headache—Epirubicin—breast cancer	2.06e-05	7.45e-05	CcSEcCtD
Doxazosin—Dizziness—Doxorubicin—breast cancer	2.01e-05	7.28e-05	CcSEcCtD
Doxazosin—Nausea—Epirubicin—breast cancer	1.95e-05	7.06e-05	CcSEcCtD
Doxazosin—Vomiting—Doxorubicin—breast cancer	1.93e-05	7e-05	CcSEcCtD
Doxazosin—Rash—Doxorubicin—breast cancer	1.91e-05	6.94e-05	CcSEcCtD
Doxazosin—Dermatitis—Doxorubicin—breast cancer	1.91e-05	6.93e-05	CcSEcCtD
Doxazosin—Headache—Doxorubicin—breast cancer	1.9e-05	6.89e-05	CcSEcCtD
Doxazosin—Nausea—Doxorubicin—breast cancer	1.8e-05	6.54e-05	CcSEcCtD
Doxazosin—CYP2C19—Metabolism—GSTM1—breast cancer	4.47e-06	4.95e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RELA—breast cancer	4.47e-06	4.95e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—BRAF—breast cancer	4.46e-06	4.94e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ESR1—breast cancer	4.46e-06	4.94e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HIF1A—breast cancer	4.45e-06	4.92e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ERBB2—breast cancer	4.44e-06	4.92e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—TYMS—breast cancer	4.42e-06	4.89e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—HMOX1—breast cancer	4.41e-06	4.89e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—AKT1—breast cancer	4.41e-06	4.88e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FN1—breast cancer	4.41e-06	4.88e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ITPR1—breast cancer	4.4e-06	4.87e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MTOR—breast cancer	4.38e-06	4.85e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CB—breast cancer	4.38e-06	4.85e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NCOR1—breast cancer	4.37e-06	4.83e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PLA2G4A—breast cancer	4.37e-06	4.83e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTM1—breast cancer	4.37e-06	4.83e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NFKBIA—breast cancer	4.36e-06	4.82e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF1—breast cancer	4.35e-06	4.81e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT2—breast cancer	4.35e-06	4.81e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LEP—breast cancer	4.34e-06	4.81e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—EGFR—breast cancer	4.33e-06	4.79e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NOTCH1—breast cancer	4.31e-06	4.77e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CAV1—breast cancer	4.3e-06	4.76e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GPX1—breast cancer	4.28e-06	4.74e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KDR—breast cancer	4.25e-06	4.71e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP1A1—breast cancer	4.24e-06	4.69e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ABCB1—breast cancer	4.24e-06	4.69e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CG—breast cancer	4.22e-06	4.67e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KIT—breast cancer	4.22e-06	4.67e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APC—breast cancer	4.22e-06	4.67e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCL8—breast cancer	4.21e-06	4.66e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ERCC2—breast cancer	4.2e-06	4.65e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—HRAS—breast cancer	4.19e-06	4.63e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GPX1—breast cancer	4.18e-06	4.63e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CD—breast cancer	4.17e-06	4.62e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EGF—breast cancer	4.17e-06	4.61e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—TYMS—breast cancer	4.16e-06	4.6e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ESR1—breast cancer	4.15e-06	4.59e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP1A1—breast cancer	4.14e-06	4.58e-05	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—PIK3CA—breast cancer	4.14e-06	4.58e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SERPINE1—breast cancer	4.13e-06	4.57e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CD—breast cancer	4.12e-06	4.56e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CDKN1B—breast cancer	4.11e-06	4.55e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PLA2G4A—breast cancer	4.11e-06	4.55e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NCOR1—breast cancer	4.11e-06	4.55e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTM1—breast cancer	4.11e-06	4.55e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ERCC2—breast cancer	4.1e-06	4.54e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FN1—breast cancer	4.1e-06	4.53e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—KRAS—breast cancer	4.09e-06	4.52e-05	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AKT1—breast cancer	4.07e-06	4.5e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ALB—breast cancer	4.07e-06	4.5e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NFKBIA—breast cancer	4.05e-06	4.48e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—MAPK3—breast cancer	4.04e-06	4.47e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CASP3—breast cancer	4.03e-06	4.46e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL2—breast cancer	4.03e-06	4.46e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOTCH1—breast cancer	4.01e-06	4.44e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL6—breast cancer	4.01e-06	4.43e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—BRAF—breast cancer	3.97e-06	4.39e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—MTHFR—breast cancer	3.95e-06	4.37e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NOS3—breast cancer	3.94e-06	4.36e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GPX1—breast cancer	3.94e-06	4.36e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCND1—breast cancer	3.93e-06	4.34e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KIT—breast cancer	3.92e-06	4.34e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CG—breast cancer	3.92e-06	4.34e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APC—breast cancer	3.92e-06	4.34e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—JUN—breast cancer	3.92e-06	4.33e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP1A1—breast cancer	3.9e-06	4.32e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—NOS3—breast cancer	3.89e-06	4.31e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CTNNB1—breast cancer	3.89e-06	4.3e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EGF—breast cancer	3.87e-06	4.29e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ERCC2—breast cancer	3.87e-06	4.28e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF1—breast cancer	3.86e-06	4.27e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT2—breast cancer	3.86e-06	4.27e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—MTHFR—breast cancer	3.86e-06	4.27e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—EGFR—breast cancer	3.84e-06	4.25e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—breast cancer	3.81e-06	4.22e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CDKN1A—breast cancer	3.8e-06	4.2e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTEN—breast cancer	3.79e-06	4.19e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PIK3CA—breast cancer	3.76e-06	4.16e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—MAPK3—breast cancer	3.75e-06	4.15e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MDM2—breast cancer	3.74e-06	4.14e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RAF1—breast cancer	3.73e-06	4.12e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RELA—breast cancer	3.71e-06	4.11e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CD—breast cancer	3.71e-06	4.1e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAPK8—breast cancer	3.71e-06	4.1e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AKT1—breast cancer	3.7e-06	4.09e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ERBB2—breast cancer	3.69e-06	4.08e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—BRAF—breast cancer	3.68e-06	4.08e-05	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PIK3CA—breast cancer	3.67e-06	4.06e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SERPINE1—breast cancer	3.67e-06	4.06e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CAV1—breast cancer	3.65e-06	4.03e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MTOR—breast cancer	3.64e-06	4.03e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CB—breast cancer	3.64e-06	4.03e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—MTHFR—breast cancer	3.64e-06	4.02e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—KRAS—breast cancer	3.63e-06	4.02e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CB—breast cancer	3.59e-06	3.97e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF1—breast cancer	3.59e-06	3.97e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT2—breast cancer	3.59e-06	3.97e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—EGFR—breast cancer	3.57e-06	3.95e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—breast cancer	3.56e-06	3.94e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CAV1—breast cancer	3.56e-06	3.94e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SRC—breast cancer	3.51e-06	3.89e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NOS3—breast cancer	3.5e-06	3.87e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCL8—breast cancer	3.5e-06	3.87e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.48e-06	3.85e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—HRAS—breast cancer	3.47e-06	3.84e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	3.45e-06	3.81e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—breast cancer	3.42e-06	3.79e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	3.42e-06	3.78e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	3.41e-06	3.78e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	3.41e-06	3.77e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—STAT3—breast cancer	3.39e-06	3.75e-05	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	3.38e-06	3.74e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—KRAS—breast cancer	3.37e-06	3.73e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CAV1—breast cancer	3.35e-06	3.71e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CASP3—breast cancer	3.35e-06	3.7e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL2—breast cancer	3.34e-06	3.7e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	3.34e-06	3.69e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL6—breast cancer	3.33e-06	3.68e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MDM2—breast cancer	3.32e-06	3.68e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CG—breast cancer	3.32e-06	3.67e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RAF1—breast cancer	3.31e-06	3.66e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RELA—breast cancer	3.3e-06	3.65e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ERBB2—breast cancer	3.28e-06	3.62e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCND1—breast cancer	3.26e-06	3.61e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOS3—breast cancer	3.25e-06	3.6e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—JUN—breast cancer	3.25e-06	3.6e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CG—breast cancer	3.24e-06	3.59e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAPK3—breast cancer	3.24e-06	3.58e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MTOR—breast cancer	3.23e-06	3.58e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	3.23e-06	3.58e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	3.23e-06	3.57e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—breast cancer	3.16e-06	3.5e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	3.15e-06	3.49e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MYC—breast cancer	3.15e-06	3.48e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTEN—breast cancer	3.14e-06	3.48e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TGFB1—breast cancer	3.14e-06	3.48e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCL8—breast cancer	3.11e-06	3.44e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTEN—breast cancer	3.1e-06	3.43e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	3.1e-06	3.43e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MDM2—breast cancer	3.09e-06	3.42e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—HRAS—breast cancer	3.09e-06	3.41e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EGFR—breast cancer	3.08e-06	3.41e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK8—breast cancer	3.08e-06	3.4e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RAF1—breast cancer	3.08e-06	3.4e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AKT1—breast cancer	3.07e-06	3.39e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RELA—breast cancer	3.06e-06	3.39e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CG—breast cancer	3.05e-06	3.38e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ERBB2—breast cancer	3.04e-06	3.37e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	3.03e-06	3.36e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	3e-06	3.32e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MTOR—breast cancer	3e-06	3.32e-05	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	3e-06	3.32e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CASP3—breast cancer	2.97e-06	3.29e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL2—breast cancer	2.97e-06	3.28e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL6—breast cancer	2.95e-06	3.27e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CD—breast cancer	2.92e-06	3.23e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SRC—breast cancer	2.92e-06	3.23e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KRAS—breast cancer	2.91e-06	3.22e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCND1—breast cancer	2.89e-06	3.2e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—JUN—breast cancer	2.89e-06	3.2e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL8—breast cancer	2.89e-06	3.19e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ALB—breast cancer	2.88e-06	3.19e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—HRAS—breast cancer	2.87e-06	3.17e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	2.87e-06	3.17e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CD—breast cancer	2.85e-06	3.15e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—breast cancer	2.84e-06	3.14e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	2.82e-06	3.12e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ALB—breast cancer	2.81e-06	3.11e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—STAT3—breast cancer	2.81e-06	3.11e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—breast cancer	2.81e-06	3.11e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	2.8e-06	3.1e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTEN—breast cancer	2.79e-06	3.09e-05	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	2.79e-06	3.09e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CASP3—breast cancer	2.76e-06	3.06e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL2—breast cancer	2.76e-06	3.05e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NOS3—breast cancer	2.76e-06	3.05e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL6—breast cancer	2.74e-06	3.04e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK8—breast cancer	2.73e-06	3.02e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AKT1—breast cancer	2.72e-06	3.02e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NOS3—breast cancer	2.69e-06	2.98e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCND1—breast cancer	2.69e-06	2.98e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK3—breast cancer	2.69e-06	2.97e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CD—breast cancer	2.69e-06	2.97e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—JUN—breast cancer	2.68e-06	2.97e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	2.67e-06	2.96e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	2.66e-06	2.95e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ALB—breast cancer	2.65e-06	2.93e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MYC—breast cancer	2.61e-06	2.89e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—breast cancer	2.61e-06	2.89e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TGFB1—breast cancer	2.61e-06	2.88e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	2.6e-06	2.88e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTEN—breast cancer	2.6e-06	2.87e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SRC—breast cancer	2.59e-06	2.87e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TP53—breast cancer	2.59e-06	2.86e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EGFR—breast cancer	2.56e-06	2.83e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CB—breast cancer	2.54e-06	2.82e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK8—breast cancer	2.54e-06	2.81e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NOS3—breast cancer	2.54e-06	2.81e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AKT1—breast cancer	2.53e-06	2.8e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—breast cancer	2.52e-06	2.79e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—breast cancer	2.52e-06	2.79e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—STAT3—breast cancer	2.5e-06	2.76e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CB—breast cancer	2.48e-06	2.75e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HRAS—breast cancer	2.47e-06	2.74e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—breast cancer	2.46e-06	2.72e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KRAS—breast cancer	2.41e-06	2.67e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SRC—breast cancer	2.41e-06	2.66e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK3—breast cancer	2.39e-06	2.64e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL6—breast cancer	2.37e-06	2.62e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—breast cancer	2.34e-06	2.59e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CB—breast cancer	2.34e-06	2.59e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MYC—breast cancer	2.32e-06	2.57e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—STAT3—breast cancer	2.32e-06	2.57e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—breast cancer	2.32e-06	2.57e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TGFB1—breast cancer	2.32e-06	2.56e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EGFR—breast cancer	2.27e-06	2.51e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	2.22e-06	2.45e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK3—breast cancer	2.22e-06	2.45e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTEN—breast cancer	2.2e-06	2.43e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CA—breast cancer	2.19e-06	2.42e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKT1—breast cancer	2.18e-06	2.42e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MYC—breast cancer	2.16e-06	2.39e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TGFB1—breast cancer	2.15e-06	2.38e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTEN—breast cancer	2.15e-06	2.37e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TP53—breast cancer	2.15e-06	2.37e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KRAS—breast cancer	2.14e-06	2.37e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EGFR—breast cancer	2.11e-06	2.33e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HRAS—breast cancer	2.05e-06	2.27e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTEN—breast cancer	2.02e-06	2.24e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KRAS—breast cancer	1.99e-06	2.21e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	1.97e-06	2.18e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL6—breast cancer	1.96e-06	2.17e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TP53—breast cancer	1.91e-06	2.11e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	1.83e-06	2.03e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HRAS—breast cancer	1.82e-06	2.02e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT1—breast cancer	1.81e-06	2.01e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AKT1—breast cancer	1.79e-06	1.98e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TP53—breast cancer	1.77e-06	1.96e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL6—breast cancer	1.74e-06	1.93e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HRAS—breast cancer	1.69e-06	1.87e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL6—breast cancer	1.62e-06	1.79e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT1—breast cancer	1.61e-06	1.78e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CA—breast cancer	1.55e-06	1.72e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CA—breast cancer	1.51e-06	1.68e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT1—breast cancer	1.5e-06	1.66e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CA—breast cancer	1.43e-06	1.58e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AKT1—breast cancer	1.27e-06	1.4e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AKT1—breast cancer	1.24e-06	1.37e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AKT1—breast cancer	1.17e-06	1.29e-05	CbGpPWpGaD
